MedTrace Logo

Use of Preoperative Gabapentin in Patients Undergoing Laparoscopic Cholecystectomy

NCT03583892 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-08-09

No results posted yet for this study

Summary

The multimodal analgesia involves the administration of two or more analgesic agents that exert their effects via different analgesic mechanisms, providing superior analgesia with fewer side effects. This multimodal analgesic regimen includes opioids, nonsteroidal antiinflammatory drugs, cyclooxygenase-2 inhibitors, gabapentinoids, local anesthetics, and peripheral nerve blocks. The aim of this study is to evaluate postoperative analgesic benefit in patients administered with 600mg oral gabapentin as premedication for laparoscopic cholecystectomy under general anesthesia, with respect to postoperative pain scores and total postoperative requirements of morphine and/or tramadol.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Gabapentin

One of the groups of patients was exposed to preoperative gabapentin. As the pain has a complex involvement of multiple mechanisms, multimodal analgesic techniques utilizing a number of drugs acting on different analgesic mechanisms are being used. In this case, some patients received gabapentin as a part of a multimodal analgesic technique.

Sponsors & Collaborators

  • Centro Hospitalar do Porto

    lead OTHER

Principal Investigators

  • Rita Saraiva, MD · Centro Hospitalar do Porto, Serviço de Anestesiologia

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-07-31
Completion
2020-07-31
FDA Drug
Yes

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03583892 on ClinicalTrials.gov